Milestone Scientific (MLSS) Non-Current Debt (2010 - 2025)

Milestone Scientific (MLSS) reported Non-Current Debt of $800000.0 for Q2 2025, up 77.78% sequentially from $450000.0 in Q2 2013.

Milestone Scientific (MLSS) Non-Current Debt (2010 - 2025) Analysis & Trends

Milestone Scientific (MLSS) has 5 years of Non-Current Debt data on file, last reported at $800000.0 in Q2 2025.

For the quarter ending Q2 2025, Non-Current Debt changed N/A year-over-year to $800000.0; the trailing twelve-month figure through Jun 2025 stood at $800000.0 (changed N/A YoY), and the FY2012 full-year result was $450000.0, up 0.69% from the prior year.
Non-Current Debt climbed to $800000.0 in Q2 2025, from $450000.0 in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $800000.0 in Q2 2025 to a low of $800000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	4.16 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	14.71 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	12.50 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	404.17 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	202.90 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	1.86 Bn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	4.58 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Milestone Scientific	33.00 Mn	31.35 Mn	1.56 Mn	-

Download Data